Both in Pharmaceuticals
RenovoRx vs Rein Therapeutics
Over the past year RNXT returned +18.3% and RNTX returned −61.6%; their daily moves had a correlation of 0.16.
RNXT +18.3% RNTX −61.6%Growth of $1, one year, split-adjusted
| Metric | RNXT | RNTX |
|---|---|---|
| Price | $1.29 | $0.6713 |
| Market cap | $58.2M | $57.9M |
| Today | 0.00% | +0.57% |
| 1 month | −7.2% | −18.6% |
| 6 months | +45.0% | −42.6% |
| Year to date | +53.6% | −42.1% |
| 1 year | +18.3% | −61.6% |
| Revenue growth (YoY) | +115.4% | — |
| Gross margin | 84.3% | — |
| Net margin | −320.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 29.5× | — |
| Net cash | $9.5M | $40.6M |
| Dividend yield | — | — |
| Volatility (60d) | 108.3% | 95.8% |
| Short % of float | 2.0% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).